Recombinant SARS-CoV-2 Spike (Imdevimab Biosimilar) antibody

Catalog No. ABIN7795161

The Human Monoclonal anti-SARS-CoV-2 Spike (Imdevimab Biosimilar) antibody is suitable to detect SARS-CoV-2 Spike (Imdevimab Biosimilar) in samples from Human. It has been validated for FACS and in vivo.

Quick Overview for Recombinant SARS-CoV-2 Spike (Imdevimab Biosimilar) antibody (ABIN7795161)

Target: SARS-CoV-2 Spike (Imdevimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: Un-conjugated

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade: Research Grade

Product Details

Expression System: Mammalian cells

Purpose: Imdevimab Biosimilar, SARS-CoV-2 Spike Monoclonal Antibody

Characteristics: The anti-SARS-CoV-2 spike monoclonal antibody imdevimab biosimilar was produced in the imdevimab biosimilar CHO cells.

Purification: Protein A or G affinity column

Purity: >95 % by reducing SDS-PAGE

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method

Isotype: IgG1, lambda

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: > 3 mg/mL

Storage: 4 °C,-20 °C

Storage Comment: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Target Details

Target: SARS-CoV-2 Spike (Imdevimab Biosimilar)

Alternative Name: Imdevimab Biosimilar

Target Type: Biosimilar